-
![]()
44
-
population pharmacokinetics and dosing optimization of linezolid in pediatric patients.[2019][antimicrob agents chemother][10.1128aac.02387-18].pdf
- Populationpharmacokinetics dosingoptimization pediatricpatients Si-ChanLi1, Qi Ye1, Hua Xu1, Long Zh
-
-
![]()
45
-
clyj, a novel pneumococcal chimeric lysin with a chap catalytic domain.[2019][antimicrob agents chemother][10.1128aac.02043-18].pdf
- novelpneumococcal chimeric lysin CHAPcatalytic domain HangYang1,4,, Yujing Gong2, Huaidong Zhang3, I
-
-
![]()
42
-
the direct and indirect inhibition effects of resveratrol against toxoplasma gondii tachyzoites in vitro.[2018][antimicrob agents chemother][10.112.pdf
- indirectinhibition effects resveratrolagainst Toxoplasmagondii tachyzoites Qi-WeiChena, Kai Donga, H
-
-
![]()
52
-
beyond membrane-lytic_ intracellular targeting mechanisms by antimicrobial peptides.[2017][antimicrob agents chemother][10.1128_aac.02340-16].pdf
- Beyondmembrane-lytic: Intracellular Targeting Mechanisms AntimicrobialPeptides Cheng-FohLe1*, Chee-M
-
-
![]()
57
-
synthetic cyclic peptomers as type iii secretion system inhibitors.[2017][antimicrob agents chemother][10.1128aac.00060-17].pdf
- Syntheticcyclic peptomers typeIII secretion system inhibitors HanhLam1, Joshua Schwochert2, Yongtong
-
向豆丁求助：有没有Chemother?
